X-67717535-G-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP3_StrongPP5_Moderate
The NM_000044.6(AR):c.2231G>T(p.Gly744Val) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000044.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Androgen resistance syndrome;C1839259:Kennedy disease Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects AR protein function (PMID: 8325932, 9768671). This variant has been observed in individual(s) with androgen insensitivity syndrome (PMID: 8096390, 8325932, 9768671). In at least one individual the variant was observed to be de novo. This variant is also known as Gly743Val. ClinVar contains an entry for this variant (Variation ID: 9857). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with valine at codon 744 of the AR protein (p.Gly744Val). The glycine residue is moderately conserved and there is a moderate physicochemical difference between glycine and valine. -
Partial androgen insensitivity syndrome Pathogenic:1
- -
Androgen resistance syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at